Verónica Rendo

A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma

Rendo, Veronica; Lee, Eudocia Q.; Bossi, Connor; Khuu, Nicholas et al.

Ingår i Science Translational Medicine, 2025

• DOI för A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma

p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics

Niklasson, Mia; Dalmo, Erika; Segerman, Anna; Rendo, Veronica et al.

Ingår i International Journal of Molecular Sciences, 2025

• DOI för p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics
• Ladda ner fulltext (pdf) av p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics

Recurrent breakpoints in the BRD4 locus reduce toxicity associated with gene amplification

Wala, Jeremiah; Dalin, Simona; Webster, Sophie; Shapira, Ofer et al.

Ingår i Cell Genomics, 2025

• DOI för Recurrent breakpoints in the BRD4 locus reduce toxicity associated with gene amplification
• Ladda ner fulltext (pdf) av Recurrent breakpoints in the BRD4 locus reduce toxicity associated with gene amplification

A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer

Rendo, Verónica; Schubert, Michael; Khuu, Nicholas; Suarez Peredo Rodriguez, Maria F. et al.

Ingår i Nature Communications, 2025

• DOI för A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer
• Ladda ner fulltext (pdf) av A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer

NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors

Rameika, Natallia; Tsiara, Ioanna; Zhang, Xiaonan; Haberek, Wawrzyniec et al.

Ingår i Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025

• DOI för NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
• Ladda ner fulltext (pdf) av NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors

A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma

Rendo, Veronica; Lee, Eudocia Q.; Bossi, Connor; Khuu, Nicholas et al.

Ingår i Science Translational Medicine, 2025

• DOI för A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma

p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics

Niklasson, Mia; Dalmo, Erika; Segerman, Anna; Rendo, Veronica et al.

Ingår i International Journal of Molecular Sciences, 2025

• DOI för p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics
• Ladda ner fulltext (pdf) av p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics

Recurrent breakpoints in the BRD4 locus reduce toxicity associated with gene amplification

Wala, Jeremiah; Dalin, Simona; Webster, Sophie; Shapira, Ofer et al.

Ingår i Cell Genomics, 2025

• DOI för Recurrent breakpoints in the BRD4 locus reduce toxicity associated with gene amplification
• Ladda ner fulltext (pdf) av Recurrent breakpoints in the BRD4 locus reduce toxicity associated with gene amplification

A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer

Rendo, Verónica; Schubert, Michael; Khuu, Nicholas; Suarez Peredo Rodriguez, Maria F. et al.

Ingår i Nature Communications, 2025

• DOI för A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer
• Ladda ner fulltext (pdf) av A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer

NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors

Rameika, Natallia; Tsiara, Ioanna; Zhang, Xiaonan; Haberek, Wawrzyniec et al.

Ingår i Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025

• DOI för NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
• Ladda ner fulltext (pdf) av NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors

Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening

Gezelius, Henrik; Enblad, Anna Pia; Lundmark, Anders; Åberg, Martin et al.

Ingår i NAR Genomics and Bioinformatics, 2024

• DOI för Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening
• Ladda ner fulltext (pdf) av Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening

Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity

Zhang, Xiaonan; Akcan, Ece; Correia, Mario S. P.; Rameika, Natallia et al.

Ingår i Biochemical Pharmacology, 2022

• DOI för Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity
• Ladda ner fulltext (pdf) av Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity

Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis

Kundu, Snehangshu; Ali, Muhammad Akhtar; Handin, Niklas; Conway, Louis P. et al.

Ingår i Journal of Experimental & Clinical Cancer Research, 2021

• DOI för Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis
• Ladda ner fulltext (pdf) av Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis

Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer

Rendo, Verónica; Kundu, Snehangshu; Rameika, Natallia; Ljungström, Viktor et al.

Ingår i Scientific Reports, 2020

• DOI för Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
• Ladda ner fulltext (pdf) av Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer

Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N-Acetyltransferase NAT2

Conway, Louis P.; Rendo, Verónica; Correia, Mario S. P.; Bergdahl, Ingvar A et al.

Ingår i Angewandte Chemie International Edition, s. 14342-14346, 2020

• DOI för Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N-Acetyltransferase NAT2
• Ladda ner fulltext (pdf) av Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N-Acetyltransferase NAT2

Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy

Rendo, Verónica; Stoimenov, Ivaylo; Mateus, André; Sjöberg, Elin et al.

Ingår i Nature Communications, 2020

• DOI för Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
• Ladda ner fulltext (pdf) av Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy

Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth

Pandzic, Tatjana; Rendo, Verónica; Lim, Jinyeong; Larsson, Chatarina et al.

Ingår i Oncotarget, s. 98646-98659, 2017

• DOI för Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth

Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

Mathot, Lucy; Kundu, Snehangshu; Ljungström, Viktor; Svedlund, Jessica et al.

Ingår i Cancer Research, s. 1730-1740, 2017

• DOI för Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

Targeting allelic loss in colorectal cancer

Rendo, Verónica

2018

• Ladda ner fulltext (pdf) av Targeting allelic loss in colorectal cancer

BMP4 induces a p21-dependent cell state shift in glioblastoma linking mesenchymal transition to senescence

Niklasson, Mia; Dalmo, Erika; Segerman, Anna; Rendo, Verónica et al.

• DOI för BMP4 induces a p21-dependent cell state shift in glioblastoma linking mesenchymal transition to senescence

Novel anti-cancer agents targeting NAT2 loss in colorectal cancer

Rameika, Natallia; Tsiara, Ioanna; Haberek, Wawrzyniec; Akcan, Ece et al.